December 16, 2024 – INCATE (INCubator for Antibacterial Therapies in Europe) is pleased to announce that two ventures have been awarded Stage II funding in its latest round: Kinzbio and the BamA inhibitor project from [...]
More news
© Marek Kruszewski Researchers from the Helmholtz Centre for Infection Research in Braunschweig [...]
credits: Interfinity On April 9th, 2025, 20:30, at Voltahalle Basel, the Interfinity Festival, [...]
Puray, together with Munich University of Applied Sciences, has been awarded a prestigious €300k grant [...]
Photo credits: Phiogen PHIOGEN, a Texas-based venture developing off-the-shelf live biotherapeutic products, is excited [...]
Photo credits: INCATE Cavenagh Health exists to foster innovation and support the creation of new [...]
Antimicrobial resistance (AMR) is a global growing threat. Only through closer collaboration across all [...]
September 19th, 2024 – INCATE, the INCubator for Antibacterial Therapies in Europe, is glad to [...]
September 10th, 2024 – INCATE, the INCubator for Antibacterial Therapies in Europe, is pleased [...]
